Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Shevde

Showing results (41-50 of 51) with videos related to

Pageof 6
Sort By:
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 10, 2002
Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptorsPeterson Pathrose, Olga Barmina, Ching-Yi Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formationNirupama K Shevde, Lori A Plum, Margaret Clagett-Dame, et al.
Journal of Cellular Biochemistry|January 10, 2003
Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcriptionJ Wesley Pike, Peterman Pathrose, Olga Barmina, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1A C Bendixen, N K Shevde, K M Dienger, et al.
Endocrinology|August 23, 2001
Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factorD M Huber, A C Bendixen, P Pathrose, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 2, 2007
Multiple enhancer regions located at significant distances upstream of the transcriptional start site mediate RANKL gene expression in response to 1,25-dihydroxyvitamin D3Sungtae Kim, Miwa Yamazaki, Lee A Zella, et al.
Journal of Tissue Engineering and Regenerative Medicine|April 22, 2009
Comparative chondrogenesis of human cell sources in 3D scaffoldsR Seda Tigli, Sourabh Ghosh, Michael M Laha, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 16, 2007
Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptorJ Wesley Pike, Mark B Meyer, Makoto Watanuki, et al.
Experimental Hematology|February 1, 1997
Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten miceP Tapley, N K Shevde, P A Schweitzer, et al.
Plos One|September 7, 2012
Endogenous fluorescence signatures in living pluripotent stem cells change with loss of potencyJayne M Squirrell, Jimmy J Fong, Carlos A Ariza, et al.
Pageof 6

Showing results (41-50 of 51) with videos related to

Sort By:
Pageof 6
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research|December 10, 2002
Inhibition of 1,25-dihydroxyvitamin D3-dependent transcription by synthetic LXXLL peptide antagonists that target the activation domains of the vitamin D and retinoid X receptorsPeterson Pathrose, Olga Barmina, Ching-Yi Chang, et al.
Proceedings of the National Academy of Sciences of the United States of America|October 11, 2002
A potent analog of 1alpha,25-dihydroxyvitamin D3 selectively induces bone formationNirupama K Shevde, Lori A Plum, Margaret Clagett-Dame, et al.
Journal of Cellular Biochemistry|January 10, 2003
Synthetic LXXLL peptide antagonize 1,25-dihydroxyvitamin D3-dependent transcriptionJ Wesley Pike, Peterman Pathrose, Olga Barmina, et al.
Proceedings of the National Academy of Sciences of the United States of America|February 28, 2001
IL-4 inhibits osteoclast formation through a direct action on osteoclast precursors via peroxisome proliferator-activated receptor gamma 1A C Bendixen, N K Shevde, K M Dienger, et al.
Endocrinology|August 23, 2001
Androgens suppress osteoclast formation induced by RANKL and macrophage-colony stimulating factorD M Huber, A C Bendixen, P Pathrose, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 2, 2007
Multiple enhancer regions located at significant distances upstream of the transcriptional start site mediate RANKL gene expression in response to 1,25-dihydroxyvitamin D3Sungtae Kim, Miwa Yamazaki, Lee A Zella, et al.
Journal of Tissue Engineering and Regenerative Medicine|April 22, 2009
Comparative chondrogenesis of human cell sources in 3D scaffoldsR Seda Tigli, Sourabh Ghosh, Michael M Laha, et al.
The Journal of Steroid Biochemistry and Molecular Biology|January 16, 2007
Perspectives on mechanisms of gene regulation by 1,25-dihydroxyvitamin D3 and its receptorJ Wesley Pike, Mark B Meyer, Makoto Watanuki, et al.
Experimental Hematology|February 1, 1997
Increased G-CSF responsiveness of bone marrow cells from hematopoietic cell phosphatase deficient viable motheaten miceP Tapley, N K Shevde, P A Schweitzer, et al.
Plos One|September 7, 2012
Endogenous fluorescence signatures in living pluripotent stem cells change with loss of potencyJayne M Squirrell, Jimmy J Fong, Carlos A Ariza, et al.
Pageof 6